| pubmed-article:55004 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:55004 | lifeskim:mentions | umls-concept:C0032961 | lld:lifeskim |
| pubmed-article:55004 | lifeskim:mentions | umls-concept:C0341628 | lld:lifeskim |
| pubmed-article:55004 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:55004 | lifeskim:mentions | umls-concept:C0150369 | lld:lifeskim |
| pubmed-article:55004 | lifeskim:mentions | umls-concept:C0002210 | lld:lifeskim |
| pubmed-article:55004 | lifeskim:mentions | umls-concept:C0237881 | lld:lifeskim |
| pubmed-article:55004 | lifeskim:mentions | umls-concept:C0750502 | lld:lifeskim |
| pubmed-article:55004 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:55004 | pubmed:dateCreated | 1976-4-2 | lld:pubmed |
| pubmed-article:55004 | pubmed:abstractText | Having plotted a curve showing the normal values of Alpha-Foeto-protein (AFP) concentration in maternal serum and amniotic fluid, its significance in the monitoring of "at risk" pregnancies was examined and critically judged in the light of statements found in the literature. According to the results gained AFP determination in maternal serum or amniotic fluid can only be used with reservation as a monitoring test in "at risk" pregnancies. In particular in Rhesus Incompatibility it was impossible to establish the degree of foetal Haemolysis or to determine the best time for premature induction. In addition an intra-uterine death could not be predicted with certainty. | lld:pubmed |
| pubmed-article:55004 | pubmed:language | ger | lld:pubmed |
| pubmed-article:55004 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:55004 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:55004 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:55004 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:55004 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:55004 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:55004 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:55004 | pubmed:issn | 0300-967X | lld:pubmed |
| pubmed-article:55004 | pubmed:author | pubmed-author:KunzJJ | lld:pubmed |
| pubmed-article:55004 | pubmed:author | pubmed-author:MaroneAA | lld:pubmed |
| pubmed-article:55004 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:55004 | pubmed:volume | 179 | lld:pubmed |
| pubmed-article:55004 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:55004 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:55004 | pubmed:pagination | 331-8 | lld:pubmed |
| pubmed-article:55004 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:55004 | pubmed:meshHeading | pubmed-meshheading:55004-Hu... | lld:pubmed |
| pubmed-article:55004 | pubmed:meshHeading | pubmed-meshheading:55004-Pr... | lld:pubmed |
| pubmed-article:55004 | pubmed:meshHeading | pubmed-meshheading:55004-Fe... | lld:pubmed |
| pubmed-article:55004 | pubmed:meshHeading | pubmed-meshheading:55004-Hy... | lld:pubmed |
| pubmed-article:55004 | pubmed:meshHeading | pubmed-meshheading:55004-Pr... | lld:pubmed |
| pubmed-article:55004 | pubmed:meshHeading | pubmed-meshheading:55004-Pr... | lld:pubmed |
| pubmed-article:55004 | pubmed:meshHeading | pubmed-meshheading:55004-Am... | lld:pubmed |
| pubmed-article:55004 | pubmed:meshHeading | pubmed-meshheading:55004-Ab... | lld:pubmed |
| pubmed-article:55004 | pubmed:meshHeading | pubmed-meshheading:55004-Pr... | lld:pubmed |
| pubmed-article:55004 | pubmed:meshHeading | pubmed-meshheading:55004-Fe... | lld:pubmed |
| pubmed-article:55004 | pubmed:meshHeading | pubmed-meshheading:55004-Pr... | lld:pubmed |
| pubmed-article:55004 | pubmed:meshHeading | pubmed-meshheading:55004-Rh... | lld:pubmed |
| pubmed-article:55004 | pubmed:meshHeading | pubmed-meshheading:55004-al... | lld:pubmed |
| pubmed-article:55004 | pubmed:meshHeading | pubmed-meshheading:55004-Ab... | lld:pubmed |
| pubmed-article:55004 | pubmed:meshHeading | pubmed-meshheading:55004-Bl... | lld:pubmed |
| pubmed-article:55004 | pubmed:meshHeading | pubmed-meshheading:55004-Fe... | lld:pubmed |
| pubmed-article:55004 | pubmed:meshHeading | pubmed-meshheading:55004-Pr... | lld:pubmed |
| pubmed-article:55004 | pubmed:meshHeading | pubmed-meshheading:55004-Pr... | lld:pubmed |
| pubmed-article:55004 | pubmed:meshHeading | pubmed-meshheading:55004-Fe... | lld:pubmed |
| pubmed-article:55004 | pubmed:meshHeading | pubmed-meshheading:55004-Pr... | lld:pubmed |
| pubmed-article:55004 | pubmed:meshHeading | pubmed-meshheading:55004-Pr... | lld:pubmed |
| pubmed-article:55004 | pubmed:meshHeading | pubmed-meshheading:55004-Pr... | lld:pubmed |
| pubmed-article:55004 | pubmed:year | 1975 | lld:pubmed |
| pubmed-article:55004 | pubmed:articleTitle | [Alpha-fetoprotein: its significance in the monitoring of "at risk" pregnancies (author's transl)]. | lld:pubmed |
| pubmed-article:55004 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:55004 | pubmed:publicationType | English Abstract | lld:pubmed |
